[89Zr]Zr-DFO-BIIB080
- Generic Name
- [89Zr]Zr-DFO-BIIB080
A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Biogen
- Target Recruit Count
- 5
- Registration Number
- NCT06454721
- Locations
- 🇺🇸
UC Davis, Sacramento, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath